SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-075489
Filing Date
2012-02-23
Accepted
2012-02-23 16:53:24
Documents
5
Period of Report
2012-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d303506d8k.htm 8-K 22199
2 SEVERANCE AND RELEASE AGREEMENT d303506dex101.htm EX-10.1 24047
3 2012 SENIOR EXECUTIVE ANNUAL BONUS PLAN d303506dex102.htm EX-10.2 11405
4 CODE OF CONDUCT AND BUSINESS ETHICS d303506dex141.htm EX-14.1 112125
5 GRAPHIC g303506img001.jpg GRAPHIC 12074
  Complete submission text file 0001193125-12-075489.txt   187917
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 12634485
SIC: 2836 Biological Products, (No Diagnostic Substances)